Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine

Journal of Analytical Toxicology

Volumn 31, Issue 7, 2007, Pages 377-382

  Wang, Guohong ^a   Vincent, Michael ^a   Rodrigues, Warren ^a   Agrawal, Alpana ^a   Moore, Christine ^a   Barhate, Rekha ^a   Abolencia, E ^a   Coulter, Cynthia ^a   Soares, James ^a   Zheng, Yi Feng ^b   Taylor, Celeste ^b   Morjana, Nihmat ^b  

^a Immunalysis Corporation   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHENAZONE; AMOBARBITAL; AMPHETAMINE; AMPICILLIN; ASCORBIC ACID; ATROPINE; BARBITAL; BENZOYLECGONINE; BUPRENORPHINE; CARBROMAL; CHLOROQUINE; CODEINE; DESIPRAMINE; DEXTROMETHORPHAN; DIAMORPHINE; DIAZEPAM; DIHYDROCODEINE; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NALBUPHINE; NALORPHINE; NORBUPRENORPINE; OXYCODONE; PARACETAMOL; PETHIDINE; SECBUTABARBITAL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG POTENCY; DRUG STRUCTURE; DRUG URINE LEVEL; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HEROIN DEPENDENCE; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; URINALYSIS;

EID: 34548813882     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.7.377     Document Type: Article

References (20)

1. Buprenorphine Therapy of Opiate Addiction, P. Kintz and P. Marquet, Eds. Humana Press, Totowa, NJ, 2002.
2. J.J. Kuhlman, S. Lalani, J. Magluilo, B. Levine, and W.D. Darwin. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J. Anal. Toxicol. 20(6): 369-378 (1996).
3. R.C. Baselt and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Chemical Toxicology Institute, Foster City, CA, 1995, p 93.
4. A. Tracqui, P. Kintz, and B. Ludes. Buprenorphine-related death among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol. 22: 430-434 (1998).
5. V. Cirimele. Separative technique for determination of buprenorphine. In Buprenorphine Therapy of Opiate Addiction, P. Kintz and P. Marquet, Eds. Humana Press, Totowa, NJ, 2002, pp 89-108.
6. E.J. Cone, C.W. Gorodetzky, D. Yousefnejad, W.F. Buchwald, and R.E. Johnson. The metabolism and excretion of buprenorphine in humans. Drug Metab. Dispos. 12(5): 577-581 (1984).
7. D.E. Moody, J.D. Laycock, A.C. Spanbauer, D.J. Crouch, R.L. Foltz, J.L. Josephs, L. Amass, and W.K. Bickel. Determination of buprenorphine in human plasma by chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 21(6): 406-414 (1997).
8. L. Debrabandere, M. Van Boven, and P. Daenens. Analysis of buprenorphine in urine specimens. J. Forensic Sci. 37(1): 82-89 (1992).
9. P. Kintz. Determination of buprenorphine and its dealkylated metabolite in human hair. J. Anal. Toxicol. 17(7): 443-444 (1993).
10. P. Kintz, A. Tracqui, P. Mangin, and Y. Edel. Sweat testing in opioid users with a sweat patch. J. Anal. Toxicol. 20(6): 393-397 (1996).
11. E.I. Miller, H.J. Torrance, and J.S. Oliver. Validation of the Immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine. J. Anal. Toxicol. 30(2): 115-119 (2006).
12. Buprenorphine ELISA Assay, Product Insert, Immunalysis Corporation, Pomona CA.
13. V. Cirimele, S. Etienne, M. Villain, B. Ludes and P. Kintz. Evaluation of the one-step ELISA kit for the detection of buprenorphine in urine, blood and hair specimens. Forensic Sci. Int. 143(2-3): 153-156 (2004).
14. V. Cirimele, P. Kintz, S. Lohner, and B. Ludes. Enzyme immunoassay validation for the detection of buprenorphine in urine. J. Anal. Toxicol. 27(2): 103-105 (2003).
15. Onestep Buprenorphine Rapidip Instatest, Product insert from Cortez Diagnostic, Inc.
16. L. Debrabandere, M. Van Boven, and P. Daenens. Development of a radioimmunoassay for the detection of buprenorphine in biological samples. Analyst 118: 137-143 (1993).
17. L. Debrabandere, M. Van Boven, and P. Daenens. Development of fluoroimmunoassay for the detection of buprenorphine in urine. J. Forensic Sci. 40(2): 250-253 (1995).
18. M. Bottcher and O. Beck. Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment. J. Anal. Toxicol. 29(8): 769-776 (2005).
19. Y.F. Zheng, P. Singh, D. Bolle, and H.-T. Liu. Immunoassay for buprenorphine and norbuprenorphine, U.S. Pat. Appl. Publ. US2005221405, 2005; CAN 143: 339588, 2005.
20. R.T. Root and M. Ghoshal. Monoclonal antibodies specific for buprenorphine and its metabolites, U.S. Pat. Appl. Publ. US2004248222, 2004; CAN 142: 22315, 2004.